COMPOSITION FOR PRINTING RECORDING MATERIALS

Details for Australian Patent Application No. 2003215868 (hide)

Owner CLARIANT INTERNATIONAL LTD

Inventors PEDRAZZI, Reinhard; SCHLOSSER, Stefan; HASEMANN, Ludwig

Pub. Number AU-A-2003215868

PCT Number PCT/IB03/01350

PCT Pub. Number WO2003/087237

Priority 0208444.0 12.04.02 GB

Filing date 10 April 2003

Wipo publication date 27 October 2003

International Classifications

C09D 011/00 Inks

D06P 001/382 General processes of dyeing or printing textiles, or general processes of dyeing leather, furs, or solid macromolecular substances in any form, classified according to the dyes, pigments, or auxiliary substances employed

D06P 003/66 Special processes of dyeing or printing textiles, or dyeing leather, furs, or solid macromolecular substances in any form, classified according to the material treated

C09B 062/085 Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 0208444.0 12.04.02 GB

4 December 2003 Application Open to Public Inspection

  Published as AU-A-2003215868

6 January 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215869-Hybrid and single chain meganucleases and use thereof

2003215867-Indol-2-ones as selective inhibitors of cyclooxygenase-2